Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Stocks Under $10 to Buy Before They Double

By Josh Enomoto, InvestorPlace Contributor

Generally speaking, investors seeking long-term success should follow the guidance of Warren Buffett rather than target cheap stocks to buy under $10. Fundamentally, the Oracle…

Wave Goodbye: 3 Stocks to Ditch as Revenge Travel Dies Down

By Josh Enomoto, InvestorPlace Contributor

Although the collective pent-up demand for social experiences amid the worst of the Covid-19 crisis led to the revenge travel phenomenon, this catalyst may be…

The Top 7 Defense Stocks for an Unsteady World

By Josh Enomoto, InvestorPlace Contributor

Given the sensitive nature of current and ongoing geopolitical flashpoints, the concept of top defense stocks to buy seems controversial. Indeed, the sector has always…

CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy

By Josh Enomoto, InvestorPlace Contributor

Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.

Michael Burry Reigns Victorious Amid Market Correction

By Josh Enomoto, InvestorPlace Contributor

With the market correction confirming the original bearish thesis of Michael Burry, the contrarian should take a victory lap.

Load More